Laboratory data and tumor markers were as follows: aspartate aminotransferase (AST): 101 U/L, alanine aminotransferase (ALT): 627 U/L, lactate dehydrogenase (LDH): 235 U/L, alkaline phosphatase (ALP): 164 U/L, gamma-glutamyl transpeptidase (γ-GTP): 154 U/L, total bilirubin: 0.9 mg/dL, α-fetoprotein (AFP): 85.5 ng/mL, protein induced by vitamin K absence or antagonist-II (PIVKA-II): 30,056 mAU/mL, and carcinoembryonic antigen (CEA): 7.0 ng/mL. The gene discussed is AFP; the disease is neoplasm.